Research suggests that the use of TNF inhibitors during pregnancy may not increase the risk of infection in children. Some studies and reviews have found that maternal exposure to these medications appears to be safe, although the topic is still being explored in various contexts, including rheumatoid arthritis and axial spondyloarthritis. The safety of TNF inhibitors during pregnancy is a subject of ongoing investigation and review.